Exponent (NASDAQ: EXPO) VP awarded 10,688 restricted stock units

Rhea-AI Filing Summary

Exponent Inc reported that Group Vice President Joseph Rakow received a grant of 10,688 restricted stock units on March 13, 2026. These RSUs represent a right to receive an equal number of shares of Exponent common stock on a 1-for-1 basis and are shown at a price of $0.00 because they are an equity award, not a market purchase. Following this grant, Rakow holds 10,688 RSUs directly, with an exercise and expiration date of March 13, 2030.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rakow Joseph

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group Vice President

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		A		10,688		03/13/2030	03/13/2030	Common Stock	10,688	(2)	10,688	D

Explanation of Responses:

1. 1-for-1.

2. Not applicable.

	By: Wendy Whitehouse For: Joseph Rakow	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Exponent (EXPO) disclose for Joseph Rakow?

Exponent disclosed that Group Vice President Joseph Rakow received a grant of 10,688 restricted stock units on March 13, 2026. These RSUs are an equity award, not a market purchase, and each unit represents one share of Exponent common stock.

How many Exponent (EXPO) restricted stock units were granted to Joseph Rakow?

Joseph Rakow was granted 10,688 restricted stock units tied to Exponent common stock. The filing shows 10,688 derivative securities owned after the transaction, indicating this award established or increased his RSU holdings to that amount as part of his compensation.

Are Joseph Rakow’s Exponent (EXPO) RSUs a stock purchase or a compensation award?

Rakow’s 10,688 Exponent RSUs are a compensation-related award, not an open-market stock purchase. The Form 4 uses transaction code “A” for grant or award and reports a price per unit of $0.00, which is typical for equity grants.

What does the 1-for-1 footnote mean for Exponent (EXPO) RSUs?

The 1-for-1 footnote means each restricted stock unit corresponds to one share of Exponent common stock. When the RSUs ultimately settle under their terms, 10,688 units would convert into 10,688 common shares, subject to any applicable vesting or settlement conditions.

When do Joseph Rakow’s Exponent (EXPO) restricted stock units expire?

The Form 4 reports an exercise and expiration date of March 13, 2030 for the 10,688 restricted stock units. This date reflects the outer limit in the award’s terms for conversion into common stock, as disclosed in the insider transaction details.